Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

Acquisition

15 Sep 2008 07:00

RNS Number : 3928D
First Derivatives PLC
15 September 2008
 

15 September 2008

First Derivatives plc 

(AIM:FDP.L, IEX:GYQ.I)

Acquisition of Market Resource Partners

The Board of First Derivatives plc ("First Derivatives" or the "Company") announces that it has acquired Market Resource Partners LLC ("MRP"), a US based technology marketing company headquartered in Philadelphia, PA, for a total consideration of up to $20 million (£11.3m) (the "Acquisition"). The Acquisition comprises an initial cash payment of $4.5m (£2.5m) and a further $1.5m (£0.8m) through the issue of 436,644 First Derivatives new ordinary shares (the "Consideration Shares"). An additional deferred consideration of up to a maximum of $14m (£7.9m) (will be payable, subject to MRP achieving certain profit goals during the two years ending 31 August 2010. The initial cash consideration will be financed from the Company's existing bank facilities.

Founded in 2002, MRP specializes in the strategic development and tactical execution of marketing and sales programs for software and technology service firms. Utilizing MRP's strategic consulting and predictive analytics, clients are in a position to make more informed decisions leading to immediate and longer term sales opportunities. MRP's clients comprise technology firms, Independent Software Vendors and channel resellers including Microsoft, Sun Microsystems and Cisco Systems. MRP employs 95 people in its office in Philadelphia, PA.

MRP achieved an EBITDA of $838,000 (£474,000) in the 12 months to 31 December 2006 and EBITDA of $335,000 (£190,000) in the 12 months to 31 December 2007 after adjusting for one-off costs of $163,000 (£92,000) from relocating their head office. In the six months to 30 June 2008 MRP achieved EBITDA of $653,000 (£369,000). The vendors have warranted that MRP's net assets as at 31 August 2008 (the effective date of the transaction) were not less than $200,000 (£113,000).

The Acquisition enhances First Derivatives presence in its largest market and will help accelerate the Company's expansion into the US by enhancing its global support offering. MRP will also provide another channel to market, for the Company's products, not only to the financial sector but also to other market segments.

The Consideration Shares will rank pari passu with the Company's existing ordinary shares. Application will be made for the Consideration Shares to be admitted to trading on AIM and the IEX and dealings are expected to commence on 19 September 2008. Following Admission the enlarged issued share capital of the Company will be 13,720,468 Ordinary Shares.

First Derivatives' CEO Brian Conlon said: "MRP is one of the leaders in its field and the continuing loyalty of its customer base, which is a roll call of the world's leading technology firms, is testimony to the quality of service it provides. This transaction represents a coming together of two very like minded firms with a mutual emphasis on professionalism and customer-driven innovation.

This Acquisition gives us access to an established team of world class technology marketing professionals. We have invested significant resources in R&D and this accelerates our channel to market particularly in the U.S. and into sectors other than investment banking. The investment will also provide a springboard for establishing a greater presence in the US market and will enable us to replicate our successful nearshore model in North America"

Kevin Cunningham of MRP said "We are excited about the opportunities that this transaction provides for MRP, our clients, and our employees. It allows us to accelerate the build out of our technology infrastructure and analytic capabilities, giving us the operational scale to meet our increasingly complex client needs. It also enables us to expand further our European operations and expertise in the financial technology sector, opening up new, more diverse business opportunities for MRP."

Contact:

First Derivatives plc

Brian Conlon

Michael O'Neill

Tel: +44 (0)28 3025 2242

Charles Stanley Securities

Nominated Adviser

Russell Cook/Carl Holmes

Tel: +44 (0)20 7149 6000

Goodbody Corporate Finance 

IEX Adviser

Finbarr Griffin/ Diane Hodgson

Tel: +353 1 667 0420

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQGUUPWBUPRGAC
Date   Source Headline
2nd Oct 20237:00 amRNSNotice of Results
31st Aug 20239:18 amRNSTotal Voting Rights
15th Aug 20237:00 amRNSIssue of Equity
31st Jul 20231:59 pmRNSTotal Voting Rights
20th Jul 20233:30 pmRNSResult of AGM
28th Jun 20234:17 pmRNSPDMR Notice and Issue of Equity
27th Jun 20234:30 pmRNSNotice of AGM
5th Jun 202312:43 pmRNSHolding(s) in Company
30th May 20231:01 pmRNSHolding(s) in Company
23rd May 20237:00 amRNSResults for the year ended 28 February 2023
18th May 20237:00 amRNSKX partnering with Amazon Web Services
5th Apr 20237:00 amRNSLTIP Award
4th Apr 20231:51 pmRNSHolding(s) in Company
4th Apr 20237:00 amRNSFY23 trading update
20th Mar 20237:00 amRNSGeneral availability of kdb Insights Enterprise
28th Feb 20238:39 amRNSTotal Voting Rights
13th Feb 20234:43 pmRNSIssue of Equity
30th Dec 202210:06 amRNSTotal Voting Rights
22nd Dec 20224:15 pmRNSHolding(s) in Company
20th Dec 20224:02 pmRNSIssue of Equity
14th Dec 20222:01 pmRNSHolding(s) in Company
30th Nov 20228:47 amRNSTotal Voting Rights
15th Nov 20227:00 amRNSIssue of Equity
31st Oct 20227:00 amRNSDirector/PDMR Shareholding
21st Oct 202211:38 amRNSDirector/PDMR Shareholding
18th Oct 20227:00 amRNSResults for the six months ended 31 August 2022
6th Oct 20222:02 pmRNSHolding(s) in Company
22nd Sep 20228:06 amRNSHolding(s) in Company
7th Sep 20227:00 amRNSNotice of Results
31st Aug 202210:09 amRNSTotal Voting Rights
16th Aug 20225:50 pmRNSIssue of Equity
5th Aug 20227:00 amRNSAppointment of Ashok Reddy as CEO of KX
2nd Aug 20229:49 amRNSHolding(s) in Company
29th Jul 202210:43 amRNSTotal Voting Rights
19th Jul 20227:00 amRNSIssue of Equity
7th Jul 20223:24 pmRNSResult of AGM
30th Jun 202212:30 pmRNSTotal Voting Rights
23rd Jun 20226:01 pmRNSIssue of Equity
8th Jun 20223:43 pmRNSNotice of AGM
31st May 202210:18 amRNSTotal Voting Rights
23rd May 20226:31 pmRNSRNS PDMR notice Issue of Equity
10th May 20227:00 amRNSResults for the year ended 28 February 2022
3rd May 20223:00 pmRNSHolding(s) in Company
26th Apr 20226:17 pmRNSHolding(s) in Company
11th Apr 20226:28 pmRNSTR1 - Notification of Major Holdings
6th Apr 20227:00 amRNSTrading update
5th Apr 20227:00 amRNSHolding(s) in Company
1st Mar 20227:00 amRNSKX Strategic Partnership Agreement with Microsoft
28th Feb 20225:52 pmRNSIssue of Equity
3rd Feb 20221:04 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.